Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

CTCF cooperates with CtIP to drive homologous recombination repair of double-strand breaks.

Hwang SY, Kang MA, Baik CJ, Lee Y, Hang NT, Kim BG, Han JS, Jeong JH, Park D, Myung K, Lee JS.

Nucleic Acids Res. 2019 Sep 26;47(17):9160-9179. doi: 10.1093/nar/gkz639.

2.

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function.

Baik CH, Geer M, Travis OK, Cornelius DC.

J Vis Exp. 2019 Jun 2;(148). doi: 10.3791/58961.

PMID:
31205301
3.

Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.

Goulart BHL, Silgard ET, Baik CS, Bansal A, Sun Q, Durbin EB, Hands I, Shah D, Arnold SM, Ramsey SD, Kavuluru R, Schwartz SM.

JCO Clin Cancer Inform. 2019 May;3:1-15. doi: 10.1200/CCI.18.00098.

4.

NLRP3 inflammasome activation in platelets in response to sepsis.

Cornelius DC, Baik CH, Travis OK, White DL, Young CM, Austin Pierce W, Shields CA, Poudel B, Williams JM.

Physiol Rep. 2019 May;7(9):e14073. doi: 10.14814/phy2.14073.

5.

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.

Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton AM, Riddell SR.

Cancer Immunol Res. 2019 Jun;7(6):910-922. doi: 10.1158/2326-6066.CIR-18-0402. Epub 2019 May 1.

PMID:
31043415
6.

Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.

Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE.

Lung Cancer. 2019 Feb;128:74-90. doi: 10.1016/j.lungcan.2018.12.003. Epub 2018 Dec 6.

PMID:
30642457
7.

Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non-Small Cell Lung Cancer.

Jacky J, Baik C.

J Adv Pract Oncol. 2017 Nov-Dec;8(7):729-735. Epub 2017 Nov 1. Review. No abstract available.

8.

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers.

Peters S, Stahel R, Bubendorf L, Bonomi P, Villegas A, Kowalski DM, Baik CS, Isla D, Carpeno JC, Garrido P, Rittmeyer A, Tiseo M, Meyenberg C, de Haas S, Lam LH, Lu MW, Stinchcombe TE.

Clin Cancer Res. 2019 Jan 1;25(1):64-72. doi: 10.1158/1078-0432.CCR-18-1590. Epub 2018 Sep 11.

PMID:
30206164
9.

Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.

Guerriero MK, Redman MW, Baker KK, Martins RG, Eaton K, Chow LQ, Santana-Davila R, Baik C, Goulart BH, Lee S, Rodriguez CP.

Cancer. 2018 Jul 1;124(13):2841-2849. doi: 10.1002/cncr.31407. Epub 2018 Apr 18.

10.

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM.

N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.

11.

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies.

Rodriguez CP, Martins RG, Baik C, Chow LQ, Santana-Davila R, Goulart BH, Lee S, Eaton KD.

Head Neck. 2018 Mar;40(3):584-589. doi: 10.1002/hed.25020. Epub 2017 Dec 28.

PMID:
29283469
12.

Color-selective photodetection from intermediate colloidal quantum dots buried in amorphous-oxide semiconductors.

Cho KS, Heo K, Baik CW, Choi JY, Jeong H, Hwang S, Lee SY.

Nat Commun. 2017 Oct 10;8(1):840. doi: 10.1038/s41467-017-00893-x.

13.

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.

Baik CS, Rubin EH, Forde PM, Mehnert JM, Collyar D, Butler MO, Dixon EL, Chow LQM.

Clin Cancer Res. 2017 Sep 1;23(17):4992-5002. doi: 10.1158/1078-0432.CCR-16-3066.

14.

Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.

Baik CS, Myall NJ, Wakelee HA.

Oncologist. 2017 Jul;22(7):786-796. doi: 10.1634/theoncologist.2016-0458. Epub 2017 May 9. Review.

15.

Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Chamberlain MC, Baik CS, Gadi VK, Bhatia S, Chow LQ.

Neuro Oncol. 2017 Jan;19(1):i1-i24. doi: 10.1093/neuonc/now197. Review.

16.

Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.

Pellini Ferreira B, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R, Rodriguez CP.

Laryngoscope. 2017 Jul;127(7):1583-1588. doi: 10.1002/lary.26422. Epub 2016 Dec 1.

PMID:
27905113
17.

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.

Chow LQM, Morishima C, Eaton KD, Baik CS, Goulart BH, Anderson LN, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM, Disis ML, Martins RG.

Clin Cancer Res. 2017 May 15;23(10):2442-2450. doi: 10.1158/1078-0432.CCR-16-1934. Epub 2016 Nov 3.

18.

Expectations of Graduate Communication Skills in Professional Veterinary Practice.

Haldane S, Hinchcliff K, Mansell P, Baik C.

J Vet Med Educ. Summer 2017;44(2):268-279. doi: 10.3138/jvme.1215-193R. Epub 2016 Sep 30.

PMID:
27689946
19.

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.

Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE.

Lancet Oncol. 2016 Jul;17(7):984-993. doi: 10.1016/S1470-2045(16)30146-2. Epub 2016 Jun 6.

20.

Exciton Recombination, Energy-, and Charge Transfer in Single- and Multilayer Quantum-Dot Films on Silver Plasmonic Resonators.

Shin T, Cho KS, Yun DJ, Kim J, Li XS, Moon ES, Baik CW, Il Kim S, Kim M, Choi JH, Park GS, Shin JK, Hwang S, Jung TS.

Sci Rep. 2016 May 17;6:26204. doi: 10.1038/srep26204.

21.
22.

Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.

Araki D, Redman MW, Martins R, Eaton K, Baik C, Chow L, Goulart B, Lee S, Santana-Davila R, Liao J, Parvathaneni U, Laramore G, Futran N, Mendez E, Bhrany A, Rodriguez CP.

Head Neck. 2016 Sep;38(9):1318-23. doi: 10.1002/hed.24437. Epub 2016 Apr 7.

PMID:
27061333
23.

Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.

Park JA, Lee HH, Kwon HS, Baik CR, Song SA, Lee JN.

Transfus Med Rev. 2016 Jan;30(1):6-14. doi: 10.1016/j.tmrv.2015.09.001. Epub 2015 Sep 28. Review.

PMID:
26481836
24.

Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication.

Baik CS, Wu D, Smith C, Martins RG, Pritchard CC.

J Thorac Oncol. 2015 Oct;10(10):e97-9. doi: 10.1097/JTO.0000000000000586. No abstract available.

25.

Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer.

Baik CS, Chamberlain MC, Chow LQ.

J Thorac Oncol. 2015 Sep;10(9):1268-1278. doi: 10.1097/JTO.0000000000000615. Review.

26.

Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women.

Baik CS, Brasky TM, Pettinger M, Luo J, Gong Z, Wactawski-Wende J, Prentice RL.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):790-7. doi: 10.1158/1055-9965.EPI-14-1322. Epub 2015 Feb 10.

27.

Combination of stereotactic ablative body radiation with targeted therapies.

Zeng J, Baik C, Bhatia S, Mayr N, Rengan R.

Lancet Oncol. 2014 Sep;15(10):e426-34. doi: 10.1016/S1470-2045(14)70026-9. Review.

PMID:
25186046
28.

Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.

Blevins DP, Dadu R, Hu M, Baik C, Balachandran D, Ross W, Gunn B, Cabanillas ME.

Thyroid. 2014 May;24(5):918-22. doi: 10.1089/thy.2012.0598. Epub 2014 Mar 17.

29.

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.

Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB, Baik CS, Lane DS, Manson JE, Vitolins MZ, Allison MA, Tang JY, Wactawski-Wende J.

Int J Cancer. 2014 Oct 15;135(8):1869-83. doi: 10.1002/ijc.28823. Epub 2014 Mar 20.

30.

Adjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-institutional Experience.

Yan J, Liu Q, Moseley JN, Baik CS, Chow LQ, Goulart BH, Zlotnick D, Papanicolau-Sengos A, Gallaher I, Knopp JM, Zeng J, Patel S.

Am J Clin Oncol. 2016 Jun;39(3):223-7. doi: 10.1097/COC.0000000000000044.

31.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

Hansen JA, Hanash SM, Tabellini L, Baik C, Lawler RL, Grogan BM, Storer B, Chin A, Johnson M, Wong CH, Zhang Q, Martin PJ, McDonald GB.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1323-30. doi: 10.1016/j.bbmt.2013.06.011. Epub 2013 Jun 17.

32.

Anti-solvent derived non-stacked reduced graphene oxide for high performance supercapacitors.

Yoon Y, Lee K, Baik C, Yoo H, Min M, Park Y, Lee SM, Lee H.

Adv Mater. 2013 Aug 27;25(32):4437-44. doi: 10.1002/adma.201301230. Epub 2013 Jun 21.

PMID:
23788264
33.

The role of chemotherapy in the management of stage IIIA non-small cell lung cancer.

Baik CS, Vallières E, Martins RG.

Am Soc Clin Oncol Educ Book. 2013:320-5. doi: 10.1200/EdBook_AM.2013.33.320. Review.

34.

EGFR mutations in squamous cell lung cancer in never-smokers.

Baik CS, Pritchard CC, Eaton KD, Chow LQ.

J Thorac Oncol. 2013 Jan;8(1):e6-7. doi: 10.1097/JTO.0b013e3182762d49. No abstract available.

35.

Partial oligomerization of pyolysin induced by a disulfide-tethered mutant.

Pokrajac L, Baik C, Harris JR, Sarraf NS, Palmer M.

Biochem Cell Biol. 2012 Dec;90(6):709-17. doi: 10.1139/o2012-029. Epub 2012 Sep 27.

PMID:
23016571
36.

Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.

Brasky TM, Baik CS, Slatore CG, Alvarado M, White E.

J Thorac Oncol. 2012 Oct;7(10):1503-12.

37.

A strategically designed porous iron-iron oxide matrix on graphene for heavy metal adsorption.

Bhunia P, Kim G, Baik C, Lee H.

Chem Commun (Camb). 2012 Oct 11;48(79):9888-90. doi: 10.1039/c2cc35120j. Epub 2012 Aug 29.

PMID:
22932929
38.

Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study.

Brasky TM, Baik CS, Slatore CG, Potter JD, White E.

Lung Cancer. 2012 Aug;77(2):260-4. doi: 10.1016/j.lungcan.2012.04.015. Epub 2012 May 17.

39.

Estrogen signaling in lung cancer: an opportunity for novel therapy.

Baik CS, Eaton KD.

Cancers (Basel). 2012 Sep 25;4(4):969-88. doi: 10.3390/cancers4040969.

40.

Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells.

Kim B, Yoon BS, Moon JH, Kim J, Jun EK, Lee JH, Kim JS, Baik CS, Kim A, Whang KY, You S.

Exp Mol Med. 2012 Jan 31;44(1):26-35. doi: 10.3858/emm.2012.44.1.002.

41.

Inhibiting olefin cis, trans-photoisomerization and enhancing electron-accepting ability of a diboryl compound by metal chelation.

Baik C, Wang S.

Chem Commun (Camb). 2011 Sep 7;47(33):9432-4. doi: 10.1039/c1cc13054d. Epub 2011 Jul 21.

PMID:
21776526
42.

Graphene/carbon nanotube hybrid-based transparent 2D optical array.

Kim UJ, Lee IH, Bae JJ, Lee S, Han GH, Chae SJ, Güneş F, Choi JH, Baik CW, Kim SI, Kim JM, Lee YH.

Adv Mater. 2011 Sep 1;23(33):3809-14. doi: 10.1002/adma.201101622. Epub 2011 Jul 19.

PMID:
21769950
43.

Comparison of bolus transit patterns identified by esophageal impedance to barium esophagram in patients with dysphagia.

Cho YK, Choi MG, Oh SN, Baik CN, Park JM, Lee IS, Kim SW, Choi KY, Chung IS.

Dis Esophagus. 2012 Jan;25(1):17-25. doi: 10.1111/j.1442-2050.2011.01212.x. Epub 2011 Jun 10.

PMID:
21668570
44.

Selective formation of GaN-based nanorod heterostructures on soda-lime glass substrates by a local heating method.

Hong YJ, Kim YJ, Jeon JM, Kim M, Choi JH, Baik CW, Kim SI, Park SS, Kim JM, Yi GC.

Nanotechnology. 2011 May 20;22(20):205602. doi: 10.1088/0957-4484/22/20/205602. Epub 2011 Mar 28.

PMID:
21444965
45.

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.

Hanash SM, Baik CS, Kallioniemi O.

Nat Rev Clin Oncol. 2011 Mar;8(3):142-50. doi: 10.1038/nrclinonc.2010.220. Review.

PMID:
21364687
46.

Single boryl isomerization in silyl-bridged photochromic diboryl dyes.

Murphy SK, Baik C, Lu JS, Wang S.

Org Lett. 2010 Nov 19;12(22):5266-9. doi: 10.1021/ol102319t. Epub 2010 Oct 14.

PMID:
20945855
47.

Switching of a single boryl center in π-conjugated photochromic polyboryl compounds and its impact on fluorescence quenching.

Baik C, Murphy SK, Wang S.

Angew Chem Int Ed Engl. 2010 Oct 25;49(44):8224-7. doi: 10.1002/anie.201003144. No abstract available.

PMID:
20857467
48.

Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study.

Baik CS, Strauss GM, Speizer FE, Feskanich D.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2525-33. doi: 10.1158/1055-9965.EPI-10-0450. Epub 2010 Aug 25.

49.

Molecular design of near-IR harvesting unsymmetrical squaraine dyes.

Kim S, Mor GK, Paulose M, Varghese OK, Baik C, Grimes CA.

Langmuir. 2010 Aug 17;26(16):13486-92. doi: 10.1021/la101257b.

PMID:
20695595
50.

Cholesterol microcrystals and cochleate cylinders: attachment of pyolysin oligomers and domain 4.

Harris JR, Lewis RJ, Baik C, Pokrajac L, Billington SJ, Palmer M.

J Struct Biol. 2011 Jan;173(1):38-45. doi: 10.1016/j.jsb.2010.07.010. Epub 2010 Aug 1.

PMID:
20682347

Supplemental Content

Support Center